Vasundhara Rasayans Limited (BOM:538634)
151.40
-2.00 (-1.30%)
At close: Jan 16, 2026
Vasundhara Rasayans Revenue
Vasundhara Rasayans had revenue of 88.21M INR in the quarter ending September 30, 2025, a decrease of -9.83%. This brings the company's revenue in the last twelve months to 329.60M, down -10.38% year-over-year. In the fiscal year ending March 31, 2025, Vasundhara Rasayans had annual revenue of 339.90M, down -8.18%.
Revenue (ttm)
329.60M
Revenue Growth
-10.38%
P/S Ratio
1.37
Revenue / Employee
9.99M
Employees
33
Market Cap
450.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 339.90M | -30.28M | -8.18% |
| Mar 31, 2024 | 370.18M | -9.23M | -2.43% |
| Mar 31, 2023 | 379.41M | 111.91M | 41.83% |
| Mar 31, 2022 | 267.50M | 40.71M | 17.95% |
| Mar 31, 2021 | 226.80M | 13.95M | 6.56% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Kimia Biosciences | 1.26B |
| Smruthi Organics | 1.20B |
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |
| Krebs Biochemicals & Industries | 272.16M |
| Crestchem | 242.52M |
| Auro Laboratories | 221.88M |